Author:
Tsilova Scheilly L.,Schreiber Benjamin E.,Lever Rebecca,Parhizkar Maryam
Reference78 articles.
1. Imatinib: a breakthrough of targeted therapy in cancer;Iqbal;Chemother Res. Pract.,2014
2. The development and application of imatinib;Jones;Expert Opin. Drug Saf.,2005
3. Challenges in oral drug delivery and applications of lipid nanoparticles as potent oral drug carriers for managing cardiovascular risk factors;Okur;Curr. Pharm. Biotechnol.,2020
4. Effects of formulation variables on the particle size and drug encapsulation of imatinib-loaded solid lipid nanoparticles;Gupta;AAPS PharmSciTech,2016
5. Novartis Pharmaceuticals, Imatinib (QTI571) in Pulmonary Arterial Hypertension, ClinicalTrials.Gov (2011). https://clinicaltrials.gov/ct2/show/study/NCT00902174 (accessed June 29, 2022).